Biocon Foundation Cancer Task Force recommends guidelines for Cancer Care

Biocon Foundation, Kiran Mazumdar-Shaw said, “Given that a third of oral cancer cases in the world are reported in India, it is a huge opportunity for India to be at the forefront, both in the areas of policy-making and therapeutic innovation, according to a release here on Monday.

Bengaluru: Biocon Foundation recently launched the Oral Cancer Task Force to mark World Cancer Day, with an expert committee comprising leading oncologists from all over India.

Speaking on the occasion, the Convenor of the Task Force and Founder and Managing Trustee of Biocon Foundation, Kiran Mazumdar-Shaw said, “Given that a third of oral cancer cases in the world are reported in India, it is a huge opportunity for India to be at the forefront, both in the areas of policy-making and therapeutic innovation, according to a release here on Monday.

"We should not be restricted to the low end of the spectrum but go beyond, to research in epidemiology, genetics and all that goes with diagnosis and treatment. We should aspire to achieve the best outcomes for head and neck cancer with new discoveries coming out of translational research, technologies and approaches like bio-specific antibodies and checkpoint inhibitors to drive the best possible treatment. Our aim should be to move from cancer care to cancer cure”, she added.

She said that although there are global guidelines for the management of head and neck cancer, India with its huge head and neck cancer burden has several demographic and genetic peculiarities, which require focus and specific therapeutic guidelines. The Task Force met with the objective of identifying optimal treatment for head and neck cancer, based on existing evidence on best outcomes among Indian patients.

Dr G K Rath, Head, National Cancer Institute, AIIMS, and the Chair of the meeting said, “Every patient has the right to receive ideal and optimal care, and healthcare should be made accessible to all. We should be able to offer both the ideal and optimal approaches to our patients.”

This consortium of 24 eminent oncologists, also included Dr Pankaj Chaturvedi and Dr Kumar Prabhash, from the Tata Memorial Hospital, Mumbai, Dr K Govind Babu, Kidwai Memorial Institute of Oncology, Bengaluru and, Dr.MunishGairola and Dr Manish Singhal from Delhi.

Dr Kumar Prabhash said, “What we follow are Western guidelines. There is a need for developing our own India specific guidelines.”

Dr Pankaj Chaturvedi said, “While addressing India specific needs, there are still many unanswered questions and research should be encouraged. We should pursue those research proposals actively and be at the forefront of research in the global space.”

Dr.Govind Babu said: “While arriving at a consensus on the management of head and neck cancer is of utmost importance, it is equally demanding to focus on prevention and early detection. All stakeholders need to participate in spreading awareness and saying no to tobacco”.

Also Read: Biocon Q3 profit zooms twofold to Rs 217 crore